196 related articles for article (PubMed ID: 38005183)
1. Anti-
Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
3. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
[TBL] [Abstract][Full Text] [Related]
4. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
5. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
[TBL] [Abstract][Full Text] [Related]
8. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
[TBL] [Abstract][Full Text] [Related]
11. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
12. Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
Eur J Med Chem; 2016 Nov; 123():895-904. PubMed ID: 27543881
[TBL] [Abstract][Full Text] [Related]
13. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
14. Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Ashworth R; Wilkinson SR; Kaiser M; Andriani G; Rodriguez A
Future Med Chem; 2013 Oct; 5(15):1763-76. PubMed ID: 24144412
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Novel 3-Nitro-1
Pelizaro BI; Batista JCZ; Portapilla GB; das Neves AR; Silva F; Carvalho DB; Shiguemoto CYK; Pessatto LR; Paredes-Gamero EJ; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; Galvão F; Oliveira KMP; Cassemiro NS; Silva DB; Piranda EM; Arruda CCP; de Albuquerque S; Baroni ACM
J Med Chem; 2024 Feb; 67(4):2584-2601. PubMed ID: 38305199
[TBL] [Abstract][Full Text] [Related]
16. Ergosterol biosynthesis and drug development for Chagas disease.
Urbina JA
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490
[TBL] [Abstract][Full Text] [Related]
17. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
Papadopoulou MV; Trunz BB; Bloomer WD; McKenzie C; Wilkinson SR; Prasittichai C; Brun R; Kaiser M; Torreele E
J Med Chem; 2011 Dec; 54(23):8214-23. PubMed ID: 22023653
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi nitroreductase: Structural features and interaction with biological membranes.
Cirqueira ML; Bortot LO; Bolean M; Aleixo MAA; Luccas PH; Costa-Filho AJ; Ramos AP; Ciancaglini P; Nonato MC
Int J Biol Macromol; 2022 Nov; 221():891-899. PubMed ID: 36100001
[TBL] [Abstract][Full Text] [Related]
19. Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme.
Carvalho AS; Salomão K; Castro SL; Conde TR; Zamith HP; Caffarena ER; Hall BS; Wilkinson SR; Boechat N
Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):315-23. PubMed ID: 24676659
[TBL] [Abstract][Full Text] [Related]
20. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
